antibiotic g 418 has been researched along with Retinitis Pigmentosa in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carr, AF; Cheetham, ME; Chen, LL; Coffey, PJ; da Cruz, L; J K Smart, M; Moore, AT; Muthiah, MN; Nommiste, B; Powner, MB; R Lane, A; Ramsden, CM; Webster, AR | 1 |
Flannery, JG; Gregory-Evans, CY; Gregory-Evans, K; Guerin, K; Hodges, MD; Mackay, DS; Moosajee, M | 1 |
2 other study(ies) available for antibiotic g 418 and Retinitis Pigmentosa
Article | Year |
---|---|
Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs.
Topics: Adult; c-Mer Tyrosine Kinase; Gentamicins; Humans; Induced Pluripotent Stem Cells; Male; Oxadiazoles; Peptide Chain Elongation, Translational; Phagocytosis; Photoreceptor Cells; Retinal Pigment Epithelium; Retinitis Pigmentosa | 2017 |
Systemic aminoglycoside treatment in rodent models of retinitis pigmentosa.
Topics: Aminoglycosides; Animals; Carrier Proteins; cis-trans-Isomerases; Codon, Nonsense; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroretinography; Eye Proteins; Fluorescent Dyes; Gentamicins; Mice; Mice, Mutant Strains; Rats; Rats, Transgenic; Retina; Retinitis Pigmentosa; Rhodopsin; Xanthenes | 2008 |